Insulin pumps are still debatable for type 1 diabetes
- PMID: 12098736
- PMCID: PMC1123559
- DOI: 10.1136/bmj.325.7354.46
Insulin pumps are still debatable for type 1 diabetes
Comment on
-
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.BMJ. 2002 Mar 23;324(7339):705. doi: 10.1136/bmj.324.7339.705. BMJ. 2002. PMID: 11909787 Free PMC article.
References
-
- Reeves ML, Seigler DE, Ryan EA, Skyler JS. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med. 1982;72:673–680. - PubMed
-
- Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care. 2000;23:583–588. - PubMed
-
- Home PD, Lindholm A, Riis A. Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial. European Insulin Aspart Study Group. Diabetes Med. 2000;17:762–770. - PubMed
-
- Tsui E, Barnie A, Ross S, Parkes R, Zinman B. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care. 2001;24:1722–1727. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical